Hyfinity Investments
Beijing, Beijinghyfinityfund.com
Overview
Hyfinity Investments is a venture capital firm located in Beijing, China, specializing in the healthcare sector. The firm is comprised of a team of experienced professionals from leading investment institutions in China, bringing together extensive knowledge in entrepreneurial operations and industry resources. Hyfinity is dedicated to integrating global medical technology innovations to enhance China's medical industry. The company focuses on pooling resources and fostering collaboration to support Chinese companies in their pursuit of becoming industry leaders.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Human Metabolomics Institute, Inc. | Aug 2025 | Series A++ | Lead |
| Nanjing Delova Biotech Co., Ltd. | Apr 2024 | Series B Extension | Co-investor |
| Daoyuan Precise Medical | Jan 2024 | Series C | Co-investor |
| Shanghai Best-Link Bioscience | Apr 2023 | Series A | Co-investor |
| InxMed Limited | May 2022 | Series B Extension | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
